Ecoevolutionary biology of pancreatic ductal adenocarcinoma.

Abstract excerpt

Pancreatic ductal adenocarcinoma (PDAC), the most common histological subtype of pancreatic cancer, is an aggressive disease predicted to be the 2nd cause of cancer mortality in the US by 2040. While first-line therapy has improved, 5-year overall survival has only increased from 5 to ∼10%, and surgical resection is only available for ∼20% of patients as most present with advanced disease, which is invariably...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Biology
• Share to Carcinoma, Pancreatic Ductal